Executive Director, Business Development
(617) 353-4569 • email@example.com
Mr. Pratt joined Boston University’s Office of Technology Development in May 2000. He worked in Technology Transfer, responsible for the transfer of technologies from the fields of physical, engineering, and computer sciences, as Director of the Office of Corporate Business Development, responsible for building long term partnerships with a special focus on technology development between Boston University/Boston Medical Center and industryand as Director of Translational Research & Corporate Relations, providing support to faculty that participate in translational research programs through proposal development, implementation of translational research, and facilitating collaboration with industry. As Executive Director Business Development he leads a team of business development professionals across all technical fields to connect Boston University discoveries with commercial opportunities.
Prior to OTD, Mr. Pratt was the Global Support Manager at NESLAB Instruments, Inc. of Portsmouth New Hampshire. His duties included management of the Application Engineering and Technical Support departments, P&L responsibility for the field service operation, and maintaining relationships with their International Dealer network.
Mr. Pratt holds a Bachelor of Arts in Physics from Holy Cross College. He is a member of the Licensing Executives Society and the Association of University Technology Managers (AUTM).
(617) 353-4567 • firstname.lastname@example.org
Nelson joined OTD’s business development group in March 2011 with a focus on medical devices and instrumentation. He manages a portfolio of medical devices, life science tools, and diagnostics inventions from BU. Prior to BU, Nelson spent 5 years at Fletcher Spaght, a boutique strategy consulting and venture capital firm with expertise in medical devices. At Fletcher Spaght, Nelson outlined the commercialization strategy of early stage companies and emerging technologies and performed due diligence supporting acquisitions and venture capital investment. In addition, Nelson has over 10 years of bench research experience in the neurosciences at the National Institute of Neurological Disorders and Stroke, Marine Biological Laboratory, and Yale University.
Nelson received his PhD in Neuroscience from Yale University and Bachelor of Arts in Biology and History from Brown University.
Director, Business Development, New Ventures
(617) 353-1828 • email@example.com
Most recently, Ms. Babu acted as the Head of Finance and Business Development at Medicine In Need (MEND), a start-up biotechnology company funded by the Bill and Melinda Gates Foundation. The company is focused on utilizing advanced technology for the delivery of drugs and vaccines to the developing world. Ms. Babu led the group in a successful IND filing for an inhaled drug used in the treatment of MDR-TB and also engaged MEND in a number of successful partnerships. Prior to MEND, Ms. Babu worked in the Business Development group at ArQule, a publicly traded biotechnology company, where she was part of the negotiation team that licensed out the Asian rights to a Phase 1 compound in a deal valued at over $150MM. Ms. Babu started her career as an investment banker at J.P. Morgan where she developed expertise in the public markets and corporate finance while focusing on debt securitizations, IPOs and mergers & acquisitions.
Ms. Babu holds an MBA degree from the University of Chicago, Booth School of Business, where she was a finalist in the New Venture Business Plan competition, and a B.A. from Bryn Mawr College where she was a recipient of a Howard Hughes Research Fellowship in Reproductive Biology .
Director, Business Development, Physical Sciences
(617) 358-3795 • firstname.lastname@example.org
Jon Jensen joined OTD in June of 2006. He manages a physical sciences portfolio of ideas and inventions, focusing much his time on semiconductors, advanced materials, energy, IT, healthcare IT, and software related technologies. He developed and now manages the Technology Development Analyst Program designed to assist OTD and its portfolio companies while providing BU students with valuable hands-on experience.
Jon received his Master of Business Administration degree from Boston University’s Graduate School of Management, and both his Bachelor of Science degree in Mechanical Engineering and his Graduate Certificate in Intellectual Property from Northeastern University. Jon has industry experience as a Test Engineer for genomics, medical device, software, and product development companies. He is also a Certified Licensing Professional™ and a USPTO Registered Patent Agent.
In his free time, Jon enjoys spending time with his family, playing soccer, and traveling.
(617) 358-3045 • email@example.com
April Effort joined the Technology Development Office at Boston University in November 2007. Prior to joining BU, she worked for the Coulter Foundation’s Translational Research Program at the University of Michigan. There she developed commercialization strategies including market, regulatory and intellectual property assessments for medical devices. Ms. Effort has also worked as an independent consultant for Arboretum Ventures and several diagnostic and medical device start-up companies.
As Director of Business Development, she manages Boston University’s portfolio of Life Science inventions. Her role also includes commercial strategy, project management, and license negotiation.
Ms. Effort is a graduate of the University of Michigan where she earned a Bachelor and a Master of Science in Cellular and Molecular Biology. In addition to laboratory research, Ms. Effort also served as a science reporter for the Michigan Daily.
Director, Business Development, Life Sciences
(617) 358-3045 • firstname.lastname@example.org
David joined OTD in July 2013, to manage the commercialization of discoveries and ideas in the life sciences, including therapeutics and diagnostics. David has over 16 years of experience growing with start-up and early-stage therapeutics and molecular diagnostics companies, working in a variety of roles including R&D, technology development, customer support, business development, and alliance management.
As Director of Business Development & Alliance Management with Idera Pharmaceuticals, David was an active deal team member for Idera’s out-licensing partnerships in cancer therapeutics and vaccine adjuvants, worth $70 million upfront and $875 million potential total. David started off his career working in a variety of scientific and management positions with the genetic analysis company Sequenom, Inc., including Manager of East Coast Operations. He worked closely with R&D, product development, bioinformatics, marketing, and Sequenom’s clients, to help improve the MassARRAY genotyping platform system and ready it for commercial launch.
David received his Ph.D. in BioOrganic Chemistry and B.Sc. in Environmental Chemistry from the University of Edinburgh, Scotland, and earned a Graduate Certificate in Intellectual Property from Northeastern University, Boston. He is an inventor on seven US patents issued in a variety of technologies related to the analysis of nucleic acids.